Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colitis 2 Urogenital Neoplasms 1 Melanoma 1 Lung Neoplasms 1 Hepatitis 1 Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 65 Nivolumab 56 Ipilimumab 34 Specimen Handling 23 Magnetic Resonance Spectroscopy 21 Cyclophosphamide 17 Biopsy 13 Radiosurgery 12 relatlimab 11 fludarabine 11 binimetinib 11 Opdualag 11 CTLA-4 Antigen 11 trametinib 10 fludarabine phosphate 8 dabrafenib 8 lifileucel 7 encorafenib 7 aldesleukin 7 atezolizumab 6 Interleukin-2 6 cemiplimab 5 X-Rays 5 Paclitaxel 5 Immunoglobulin G 5 Blood Specimen Collection 5 Taxes 4 Radiotherapy 4 Pemetrexed 4 Gemcitabine 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Melanoma × vedolizumab × 90 days × Clear all

NCT07619898 2026-06-02

PHOENIX-ECP

Therakos LLC

Phase 2 Not yet recruiting

Colitis, Hepatitis, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡